Please login to the form below
BioMarin
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of BioMarin's 2012 metabolic sales performance.
Astellas, Catalyst approvals set up record year for FDA approvals
The drug was originally developed by BioMarin, which got EU approval in 2009 and licensed it to Catalyst three years later.
BioMarin eyes 2019 FDA filing for haemophilia A gene therapy
Valrox phase 1/2 data conforms to regulatory requirements for expedited registration,” said Geoff Nichol, BioMarin’s chief medical officer, during the update. ... our development and accelerated regulatory strategy,” said BioMarin’s chief
Bayer roll-out of haemophilia drug Jivi gathers pace
BioMarin and Spark Therapeutics.
Daily Brief: Jazz Pharma and Ultragenyx approvals, Autonomous AI in retinopathy
them.”. Another variant of the disease, MPS IVa already has a treatment available – Biomarin’s Vimizim.
Spark sputters on haemophilia A gene therapy safety scare
Investors compare data unfavourably with BioMarin rival. Gene therapy developer Spark Therapeutics has seen around $1bn carved off its value after it emerged that two patients in its haemophilia A gene ... meeting the factor threshold because of
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
-
Medical Writer
-
Salary TBC
-
Senior Medical Writer
-
Salary TBC
- Global Business Development Director – Health Education
-
excellent commission
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
-
Associate Director
-
£75, 000-90, 000
-
Account Director
-
Competitive Salary Offered
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
-
Senior Account Manager
-
Competitive Salary Offered
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Account Manager / Account Director
-
Competative
-
Account Director, Medical Education
-
Salary TBC
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
Business Director
-
Competitive Salary Offered
Subscribe to our email news alerts
- Essential collaboration skills training for pharma and healthcare teams launched by Dovetail.
- Evenity back on track with FDA panel blessing in osteoporosis
- NICE gives Lilly’s Verzenios chance to compete with rivals
- J&J’s Erleada cleared for early prostate cancer in Europe
- New faces at Lucid, 90Ten and Page & Page
- 90TEN gets 2019 off to a strong start with four new hires
PMHub
Pegasus
Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...
Latest intelligence
- The UK’s new five-year pricing agreement
- Pharma has agreed to capped growth again - in exchange for uptake promises...
- Digital applications are transforming the market access landscape
- Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
- Escaping the spin cycle of sub-optimal launch
- ...
Quick links
Infographics
